Announcements

Home > Investor Relations >Announcements
Back List
Announcement of election result of Directors (including independent directors) date : 2025/05/29

SEQ_NO

2

Date of announcement

2025/05/29

Time of announcement

14:37:21

Spokesman:

Chen, Ying-Chi

Title of Spokesman:

Vice President of Sales Division

Subject

Announcement of election result of Directors

(including independent directors).

To which item it meets

paragraph 6

Date of events

2025/05/29

Statement

1.Date of occurrence of the change:2025/05/29

2.Elected or changed position (Please enter institutional director,

   institutional supervisor, independent director, natural-person

   director or natural-person supervisor):

   institutional director, independent director

3.Title and name of the previous position holder:

   Directors:

   Representative of China Chemical & Pharmaceutical Co., Ltd./

   Wang Hsieh, I-Chen

   Representative of China Chemical & Pharmaceutical Co., Ltd./

   Wang, Hou-Kai

   Representative of Wang Ming-Ning Memorial Foundation. /

   Hung, Jong-Shinn

   Representative of Wang Ming-Ning Memorial Foundation. /

   Wang, Hou-Jie

   Independent Directors

   Wang, Kuo-Chiang

   Chang, Chih-Hsien

   Kuan, Arthur

4.Resume of the previous position holder:

   Directors:

   Representative of China Chemical & Pharmaceutical Co., Ltd./

   Wang Hsieh, I-Chen/ The company Chairman

   Representative of China Chemical & Pharmaceutical Co., Ltd./

   Wang, Hou-Kai/ The company Vice Chairman

   Representative of Wang Ming-Ning Memorial Foundation. /

   Hung, Jong-Shinn/ The company Director

   Representative of Wang Ming-Ning Memorial Foundation. /

   Wang, Hou-Jie/ The company Director

   Independent Directors

   Wang, Kuo-Chiang/ The company Independent Director

   Chang, Chih-Hsien/ The company Independent Director

   Kuan, Arthur/ The company Independent Director

5.Title and name of the new position holder:

 Directors

 Representative of China Chemical & Pharmaceutical Co., Ltd./

 Wang Hsieh, I-Chen

 Representative of China Chemical & Pharmaceutical Co., Ltd./

 Wang, Hou-Kai

 Representative of Wang Ming-Ning Memorial Foundation. /

 Wang, Hou-Jie

 Representative of Wang Ming-Ning Memorial Foundation. /

 Wu, Shih-Hsuan

 Independent Directors

 Wang, Kuo-Chiang

 Kuan, Arthur

 Lee, Ming-Jye

6.Resume of the new position holder:

 Directors

 Representative of China Chemical & Pharmaceutical Co., Ltd./

 Wang Hsieh, I-Chen/ The company Chairman

 Representative of China Chemical & Pharmaceutical Co., Ltd./

 Wang, Hou-Kai/ The company Vice Chairman

 Representative of Wang Ming-Ning Memorial Foundation. /

 Wang, Hou-Jie/ The company Director

 Representative of Wang Ming-Ning Memorial Foundation. /

 Wu, Shih-Hsuan/ Director of China Chemical & Pharmaceutical

Co., Ltd.

 Independent Directors

 Wang, Kuo-Chiang/ The company Independent Director

 Kuan, Arthur/ The company Independent Director

 Lee, Ming-Jye/ Vice President of the Young Women’s Christian

 Association

7.Circumstances of change (Please enter “resignation”, “dismissal”,

term expired”, “death” or “new appointment”):term expired

8.Reason for the change: Tenure expired, Re-election of directors

9.Number of shares held by the new position holder when elected:

 Directors

 Representative of China Chemical & Pharmaceutical Co., Ltd./

 Wang Hsieh, I-Chen/ 21,575,064 shares

 Representative of China Chemical & Pharmaceutical Co., Ltd./

 Wang, Hou-Kai/ 21,575,064 shares

 Representative of Wang Ming-Ning Memorial Foundation. /

 Wang, Hou-Jie/ 1,691,982 shares

 Representative of Wang Ming-Ning Memorial Foundation. /

 Wu, Shih-Hsuan/ 1,691,982 shares

 Independent Directors

 Wang, Kuo-Chiang/ 0 shares

 Kuan, Arthur/ 0 shares

 Lee, Ming-Jye/ 0 shares

10.Original term (from __________ to __________):2022/05/25~2025/05/24

11.Effective date of the new appointment: 2025/05/29

12.Turnover rate of directors of the same term: N/A

13.Turnover rate of independent directors of the same term: N/A

14.Turnover rate of supervisors of the same term: N/A

15.Change in one-third or more of directors (Please enter “Yes” or No”): No

16.Any other matters that need to be specified (the information disclosure

  also meets the requirements of Article 7, subparagraph 6 of the Securities

  and Exchange Act Enforcement Rules, which brings forth a significant impact

  on shareholders rights or the price of the securities on public companies.): None